How should we manage patients with non-alcoholic fatty liver disease in 2007?
Open Access
- 1 June 2007
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (6), 801-808
- https://doi.org/10.1111/j.1440-1746.2007.04977.x
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Twenty‐year audit of percutaneous liver biopsy in a major Australian teaching hospitalInternal Medicine Journal, 2006
- Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2006
- The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosisComparative Hepatology, 2005
- Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver diseaseLiver International, 2005
- Histological progression of non‐alcoholic fatty liver disease in Chinese patientsAlimentary Pharmacology & Therapeutics, 2005
- Beyond insulin resistance in NASH: TNF-? or adiponectin?Hepatology, 2004
- Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT valuesHepatology, 2003
- Liver BiopsyNew England Journal of Medicine, 2001
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitisHepatology, 1999
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999